Health care startups that raised Series B in Haidian, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| X-MAGTECH | Haidian | Series B | $14.8M | 2026-06-04 |
| CSR Biotech | Haidian | Series B | $45.0M | 2026-03-10 |
| Transcend Vivoscope | Haidian | Series B | $14.5M | 2026-02-10 |
| Targeting One | Haidian | Series B | $14.0M | 2024-02-18 |
| Zhen Health | Haidian | Series B | $15.7M | 2022-01-01 |
| StoneWise | Haidian | Series B | $100.0M | 2021-04-12 |
| ZKML | Haidian | Series B | $3.1M | 2011-09-22 |
7 rows of the CSV in 5 of its 18 columns.
- The 25 health care startups in Haidian, China whose last round is Series B have raised $220.5M in total.
- 4 of them closed their most recent round in the last 12 months, $88.7M combined.
- The largest of those rounds is CSR Biotech's $45.0M Series B, dated March 2026.
- The most recent is X-MAGTECH's $14.8M Series B on 4 June 2026.
- Qiming Venture Partners is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 7 companies (28%).
- 4% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 25| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| X-MAGTECH | X-MAGTECH provides a technology platform for measuring extremely weak magnetic fields. | Health care | Series B | $14.8M | 2026-06-04 | $43.5M | IDG Capital, CAS Star, Everest Venture Capital +1 | 101 to 250 | 2018 |
| CSR Biotech | CSR Biotech provides cell imaging and data processing services for biological research. | Biotech | Series B | $45.0M | 2026-03-10 | $45.0M | Qiming Venture Partners | 51 to 100 | 2019 |
| Transcend Vivoscope | Transcend Vivoscope is a biotechnology company that offers advanced microscopy imaging products and solutions. | Biotech | Series B | $14.5M | 2026-02-10 | $14.5M | China Capital Management, Zefu Innovation, Guangzhou Tongxin Science and Technology Innovation Fund | 11 to 50 | 2016 |
| StoneWise | StoneWise builds an intelligent drug discovery platform for pharmaceutical research. | Artificial intelligence | Series B | $100.0M | 2021-04-12 | Legend Capital, Luminous Ventures (former Lightspeed China Partners), Hillhouse Ventures +1 | 51 to 100 | 2018 |
Table 1. Health care startups that raised Series B in Haidian, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 25.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CSR Biotech | CSR Biotech provides cell imaging and data processing services for biological research. | Biotech | Series B | $45.0M | 2026-03-10 | $45.0M | Qiming Venture Partners | 51 to 100 | 2019 |
| 2 | X-MAGTECH | X-MAGTECH provides a technology platform for measuring extremely weak magnetic fields. | Health care | Series B | $14.8M | 2026-06-04 | $43.5M | IDG Capital, CAS Star, Everest Venture Capital +1 | 101 to 250 | 2018 |
| 3 | Transcend Vivoscope | Transcend Vivoscope is a biotechnology company that offers advanced microscopy imaging products and solutions. | Biotech | Series B | $14.5M | 2026-02-10 | $14.5M | China Capital Management, Zefu Innovation, Guangzhou Tongxin Science and Technology Innovation Fund | 11 to 50 | 2016 |
Table 2. Health care startups that raised Series B in Haidian, China: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 2 | 8% | 1 | CSR Biotech |
| 2 | CAS Star | Startup incubator | Xian, China | 1 | 4% | 1 | X-MAGTECH |
| 3 | Everest Venture Capital | Venture capital firm | Beijing, China | 1 | 4% | 1 | X-MAGTECH |
| 4 | IDG Capital | Private equity firm | Beijing, China | 1 | 4% | 1 | X-MAGTECH |
| 5 | Zhongguancun Science City Science | Venture capital firm | Haidian, China | 1 | 4% | 1 | X-MAGTECH |
| 6 | Zefu Innovation | Venture capital firm | Zhenxing, China | 1 | 4% | 1 | Transcend Vivoscope |
| 7 | Guangzhou Tongxin Science and Technology Innovation Fund | 1 | 4% | 1 | Transcend Vivoscope | ||
| 8 | China Capital Management | Private equity firm | Beijing, China | 1 | 4% | 1 | Transcend Vivoscope |
| 9 | China Growth Capital | Venture capital firm | Beijing, China | 1 | 4% | ||
| 10 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | 1 | 4% | ||
| 11 | Hillhouse Investment | Angel group | Singapore | 1 | 4% | ||
| 12 | Wonderland Capital | Venture capital firm | Beijing, China | 1 | 4% | ||
| 13 | Jiuzhi Ziben | Venture capital firm | 1 | 4% | |||
| 14 | Redhill Capital | Venture capital firm | Guangzhou, China | 1 | 4% | ||
| 15 | Sinoking Capital | Venture capital firm | Beijing, China | 1 | 4% |
Table 3. Health care startups that raised Series B in Haidian, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 7 | 28% | $123.9M |
| Software | 6 | 24% | $5.0M |
| Artificial intelligence | 4 | 16% | |
| Education | 2 | 8% | $13.4M |
| Hardware | 1 | 4% |
Table 4. Health care startups that raised Series B in Haidian, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 25 | 100% | $6.7M |
Table 5. Health care startups that raised Series B in Haidian, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| June 2026 | 1 | 25% | $14.8M |
| March 2026 | 1 | 25% | $45.0M |
| February 2026 | 2 | 50% | $28.9M |
Table 6. Health care startups that raised Series B in Haidian, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 16% | $88.7M |
| 2025 | 1 | 4% | |
| 2024 | 1 | 4% | $14.0M |
| 2022 | 3 | 12% | $44.5M |
| 2021 | 2 | 8% | $100.0M |
| 2019 | 2 | 8% | $9.5M |
Table 7. Health care startups that raised Series B in Haidian, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 1 | 4% |
| 2015 to 2019 | 13 | 52% |
| 2010 to 2014 | 8 | 32% |
| Before 2010 | 3 | 12% |
Table 8. Health care startups that raised Series B in Haidian, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 3 | 12% |
| 11 to 50 | 12 | 50% |
| 51 to 100 | 5 | 21% |
| 101 to 250 | 2 | 8% |
| 251 to 500 | 2 | 8% |
Table 9. Health care startups that raised Series B in Haidian, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in Haidian, China. On 16 November 2026 that is 25 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 25 rows: 4 have no round amount, 0 no city and 7 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Haidian, China whose last round is Series B are on the list?
- 25, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 25 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.